Article Text
Statistics from Altmetric.com
Editor,—Selective or universal screening for Chlamydia trachomatis infections has been sugested by the World Health Organization as a primary prevention strategy.1
The improved sensitivity of the nucleic acid amplification assays for the detection of C trachomatis allows the use of urine samples, suitable for screening programmes. However, these commercial assays are expensive, which make them disadvantageous for this purpose.
Therefore, some authors have recently evaluated the accuracy and cost saving of different urine pooling strategies using polymerase chain reaction (PCR) and ligase chain reaction (LCR) tests for the screening for genital C trachomatis infections, reporting very encouraging results.2–5 As the pooling strategies need individual …